Skip to main content

01.11.2004 | Article

Diffusing capacity for carbon monoxide in children with type 1 diabetes

verfasst von: M. P. Villa, M. Montesano, M. Barreto, J. Pagani, M. Stegagno, G. Multari, R. Ronchetti

Erschienen in: Diabetologia | Ausgabe 11/2004

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Few data are available on lung dysfunction in children with diabetes. We studied the association of pulmonary function variables (flows, volumes and alveolar capillary diffusion) with disease-related variables in children with type 1 diabetes mellitus.

Methods

We studied 39 children with type 1 diabetes (mean age 10.9±2.6 years, disease duration 3.6±2.4 years, insulin·kg−1·day−1 0.77±0.31) and 30 healthy control children (mean age 10.4±3.0 years). Pulmonary function tests included spirometry, N2 wash-out and the single-breath diffusing capacity for carbon monoxide (DLCO) corrected for the alveolar volume (DLCO/VA). Glycaemic control was assessed on the basis of HbA1c, with HbA1c values of 8% or less considered to indicate good glycaemic control, and HbA1c values of 8% or more considered to indicate poor control.

Results

Children with poor glycaemic control had comparable percentage values for predicted flows and volumes but lower DLCO/VA values than children with good glycaemic control and healthy control children (86.7±12.6 vs 99.8±18.4 and 102.0±15.7; p<0.05). The predicted DLCO/VA percentages correlated with HbA1c levels (r=−0.39, p=0.013). A multiple regression analysis (stepwise model) controlling for HbA1c levels and other disease-related variables (age of disease onset, disease duration, daily insulin dose/kg, sex) identified HbA1c levels as the sole predictor of DLCO/VA in percent.

Conclusions/interpretation

In children with type 1 diabetes, the diffusing capacity diminishes early in childhood and is associated with poor metabolic control. Although low DLCO/VA levels in these children probably reflect pulmonary microangiopathy induced by type 1 diabetes, other factors presumably influencing CO diffusion capacity measurements (e.g. a left shift in HbA1c resulting in high O2 binding and low CO binding) could explain the apparent capillary and alveolar basal membrane dysfunction.
Literatur
1.
Zurück zum Zitat Spiro RG (1976) Search for a biochemical basis of diabetic microangiopathy. Diabetologia 12:1–14PubMed Spiro RG (1976) Search for a biochemical basis of diabetic microangiopathy. Diabetologia 12:1–14PubMed
2.
Zurück zum Zitat Sternberg M, Cohen-Forterre L, Peyroux J (1985) Connective tissue in diabetes mellitus. Biochemical alterations of the intercellular matrix with special reference to proteoglycans, collagens and basement membranes. Diabet Metab 11:27–50 Sternberg M, Cohen-Forterre L, Peyroux J (1985) Connective tissue in diabetes mellitus. Biochemical alterations of the intercellular matrix with special reference to proteoglycans, collagens and basement membranes. Diabet Metab 11:27–50
3.
Zurück zum Zitat Hamlin CR, Kohn RR, Luschin JH (1975) Apparent accelerated aging of human collagen in diabetes mellitus. Diabetes 24:902–904PubMed Hamlin CR, Kohn RR, Luschin JH (1975) Apparent accelerated aging of human collagen in diabetes mellitus. Diabetes 24:902–904PubMed
4.
Zurück zum Zitat Vracko R, Thorning D, Huang T W (1979) Basal lamina of alveolar epithelium and capillaries. Quantitative changes with aging and in diabetes mellitus. Am Rev Respir Dis 120:973–983PubMed Vracko R, Thorning D, Huang T W (1979) Basal lamina of alveolar epithelium and capillaries. Quantitative changes with aging and in diabetes mellitus. Am Rev Respir Dis 120:973–983PubMed
5.
Zurück zum Zitat Vogt BW, Schleicher ED, Wieland OH (1982) ε-amino-lysine-bound glucose in human tissue obtained at autopsy. Diabetes 31:1123–1127PubMed Vogt BW, Schleicher ED, Wieland OH (1982) ε-amino-lysine-bound glucose in human tissue obtained at autopsy. Diabetes 31:1123–1127PubMed
6.
Zurück zum Zitat Sandler M (1990) Is the lung a “target organ” in diabetes mellitus? Arch Intern Med 150:1385–1388CrossRefPubMed Sandler M (1990) Is the lung a “target organ” in diabetes mellitus? Arch Intern Med 150:1385–1388CrossRefPubMed
7.
Zurück zum Zitat Sandler M, Stewart RI, Gemperli BM, Hanekom C, Kuhn SH (1987) Serum alpha-1-protease inhibitor activity and pulmonary function in young insulin-dependent diabetic subjects. Respiration 52:281–289PubMed Sandler M, Stewart RI, Gemperli BM, Hanekom C, Kuhn SH (1987) Serum alpha-1-protease inhibitor activity and pulmonary function in young insulin-dependent diabetic subjects. Respiration 52:281–289PubMed
8.
Zurück zum Zitat Sandler M, Bunn AE, Stewart RI (1987) Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 135:223–229PubMed Sandler M, Bunn AE, Stewart RI (1987) Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 135:223–229PubMed
9.
Zurück zum Zitat Schuyler MR, Niewoehner DE, Inkley SR, Kohn R (1976) Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis 113:37–41PubMed Schuyler MR, Niewoehner DE, Inkley SR, Kohn R (1976) Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis 113:37–41PubMed
10.
Zurück zum Zitat Sandler M, Bunn AE, Stewart RI (1986) Pulmonary function in young insulin-dependent diabetic subjects. Chest 90:670–675PubMed Sandler M, Bunn AE, Stewart RI (1986) Pulmonary function in young insulin-dependent diabetic subjects. Chest 90:670–675PubMed
11.
Zurück zum Zitat Schnapf BM, Banks LA, Silverstein JH, Rosenbloom AL, Chesrown SE, Loughlin GM (1984) Pulmonary function in insulin-dependent diabetes mellitus with limited joint mobility. Am Rev Respir Dis 130:930–932PubMed Schnapf BM, Banks LA, Silverstein JH, Rosenbloom AL, Chesrown SE, Loughlin GM (1984) Pulmonary function in insulin-dependent diabetes mellitus with limited joint mobility. Am Rev Respir Dis 130:930–932PubMed
12.
Zurück zum Zitat Bell D, Collier A, Matthews DM, Cooksey EJ, McHardy GJ, Clarke BF (1988) Are reduced lung volumes in IDDM due to defect in connective tissue? Diabetes 37:829–831PubMed Bell D, Collier A, Matthews DM, Cooksey EJ, McHardy GJ, Clarke BF (1988) Are reduced lung volumes in IDDM due to defect in connective tissue? Diabetes 37:829–831PubMed
13.
Zurück zum Zitat Cooper BG, Taylor R, Alberti KGMM, Gibson GJ (1990) Lung function in patients with diabetes mellitus. Respir Med 84:235–239PubMed Cooper BG, Taylor R, Alberti KGMM, Gibson GJ (1990) Lung function in patients with diabetes mellitus. Respir Med 84:235–239PubMed
14.
Zurück zum Zitat Asunuma Y, Fujiya S, Ide H, Agishi Y (1985) Characteristics of pulmonary function in patients with diabetes mellitus. Diabetes Res Clin Pract 1:95–101PubMed Asunuma Y, Fujiya S, Ide H, Agishi Y (1985) Characteristics of pulmonary function in patients with diabetes mellitus. Diabetes Res Clin Pract 1:95–101PubMed
15.
Zurück zum Zitat Innocenti F, Fabbri A, Anichini R et al. (1994) Indications of reduced pulmonary function in type I (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract 25:161–168CrossRefPubMed Innocenti F, Fabbri A, Anichini R et al. (1994) Indications of reduced pulmonary function in type I (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract 25:161–168CrossRefPubMed
16.
Zurück zum Zitat Isotani H, Nakamura Y, Kameoka K et al. (1999) Pulmonary diffusing capacity, serum angiotensin-converting enzyme activity and the angiotensin-converting enzyme gene in Japanese non-insulin-dependent diabetes mellitus patients. Diabetes Res Clin Pract 43:173–177CrossRefPubMed Isotani H, Nakamura Y, Kameoka K et al. (1999) Pulmonary diffusing capacity, serum angiotensin-converting enzyme activity and the angiotensin-converting enzyme gene in Japanese non-insulin-dependent diabetes mellitus patients. Diabetes Res Clin Pract 43:173–177CrossRefPubMed
17.
Zurück zum Zitat Buckingham B, Perejda AJ, Sandborg C, Kershnar AK, Uitto J (1986) Skin, joint and pulmonary changes in type 1 diabetes mellitus. Am J Dis Child 140:420–423PubMed Buckingham B, Perejda AJ, Sandborg C, Kershnar AK, Uitto J (1986) Skin, joint and pulmonary changes in type 1 diabetes mellitus. Am J Dis Child 140:420–423PubMed
18.
Zurück zum Zitat Primhak RA, Whincup G, Tsanakas JN, Milner RDG (1987) Reduced vital capacity in insulin-dependent diabetes. Diabetes 36:324–336PubMed Primhak RA, Whincup G, Tsanakas JN, Milner RDG (1987) Reduced vital capacity in insulin-dependent diabetes. Diabetes 36:324–336PubMed
19.
Zurück zum Zitat Van Gent R, Brackel HJ, De Vroede M, Van Der Ent CK (2002) Lung function abnormalities in children with type I diabetes. Respir Med 96:976–978CrossRefPubMed Van Gent R, Brackel HJ, De Vroede M, Van Der Ent CK (2002) Lung function abnormalities in children with type I diabetes. Respir Med 96:976–978CrossRefPubMed
20.
Zurück zum Zitat Verroti A, Verini M, Chiarelli F, Verdesca V, Misticoni G, Morgese G (1993) Pulmonary function in diabetic children with or without persistent microalbuminuria. Diabetes Res Clin Pract 21:171–176CrossRefPubMed Verroti A, Verini M, Chiarelli F, Verdesca V, Misticoni G, Morgese G (1993) Pulmonary function in diabetic children with or without persistent microalbuminuria. Diabetes Res Clin Pract 21:171–176CrossRefPubMed
21.
Zurück zum Zitat American Thoracic Society (1995) Medical Section of American Lung Association. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 153:1107–1136 American Thoracic Society (1995) Medical Section of American Lung Association. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 153:1107–1136
22.
Zurück zum Zitat Clausen JL, Coates AL, Quanjer PH (1997) Measurement of lung volumes in humans: review and recommendation from an ATS/ERS workshop. Eur Respir J 10:1205–1206CrossRefPubMed Clausen JL, Coates AL, Quanjer PH (1997) Measurement of lung volumes in humans: review and recommendation from an ATS/ERS workshop. Eur Respir J 10:1205–1206CrossRefPubMed
23.
Zurück zum Zitat American Thoracic Society (1995) Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique—1995 update. Am J Respir Crit Care Med 152:2185–2198PubMed American Thoracic Society (1995) Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique—1995 update. Am J Respir Crit Care Med 152:2185–2198PubMed
24.
Zurück zum Zitat Zapletal A, Samanek M, Paul T (1987) Lung function in children and adolescents: methods, reference values. Karger, Basel Zapletal A, Samanek M, Paul T (1987) Lung function in children and adolescents: methods, reference values. Karger, Basel
25.
Zurück zum Zitat Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M (1981) Limited joint mobility in childhood diabetes indicates increased risk for microvascular disease. N Engl J Med 305:191–194PubMed Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M (1981) Limited joint mobility in childhood diabetes indicates increased risk for microvascular disease. N Engl J Med 305:191–194PubMed
26.
Zurück zum Zitat Ramirez LC, Dal Nogare A, Hsia C et al. (1991) Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus. Am J Med 91:371–376CrossRefPubMed Ramirez LC, Dal Nogare A, Hsia C et al. (1991) Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus. Am J Med 91:371–376CrossRefPubMed
27.
Zurück zum Zitat Weir DC, Jennings PE, Hendy MS (1988) Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy. Thorax 43:725–726PubMed Weir DC, Jennings PE, Hendy MS (1988) Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy. Thorax 43:725–726PubMed
28.
Zurück zum Zitat Niranjan V, McBrayer DG, Ramirez LC, Raskin P, Hsia CCW (1997) Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J Med 103:504–513CrossRefPubMed Niranjan V, McBrayer DG, Ramirez LC, Raskin P, Hsia CCW (1997) Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J Med 103:504–513CrossRefPubMed
29.
Zurück zum Zitat Weynand B, Jonckheere A, Frans A, Rahier J (1999) Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration 66:14–19CrossRefPubMed Weynand B, Jonckheere A, Frans A, Rahier J (1999) Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration 66:14–19CrossRefPubMed
30.
Zurück zum Zitat Ditzel J (1979) Changes in red cell oxygen release capacity in diabetes mellitus. Fed Proc 38:2484–2488PubMed Ditzel J (1979) Changes in red cell oxygen release capacity in diabetes mellitus. Fed Proc 38:2484–2488PubMed
31.
Zurück zum Zitat Bunn HF (1978) The glycosylation of haemoglobin: relevance to diabetes mellitus. Science 200:21–27PubMed Bunn HF (1978) The glycosylation of haemoglobin: relevance to diabetes mellitus. Science 200:21–27PubMed
32.
Zurück zum Zitat Oulhen PH, Barthetemy L, Bellet-Barthas M, Darragon T (1982) Respiratory function study on insulin-dependent diabetics (in French). Rev Fr Mal Respir 10:213–224PubMed Oulhen PH, Barthetemy L, Bellet-Barthas M, Darragon T (1982) Respiratory function study on insulin-dependent diabetics (in French). Rev Fr Mal Respir 10:213–224PubMed
33.
Zurück zum Zitat Fuso L, Cotroneo P, Basso S et al. (1996) Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus. Chest 110:1009–1013PubMed Fuso L, Cotroneo P, Basso S et al. (1996) Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus. Chest 110:1009–1013PubMed
34.
Zurück zum Zitat Schernthaner G, Haber P, Krummer R, Ludwing H (1977) Lung elasticity in juvenile onset diabetes mellitus. Am Rev Respir Dis 116:544–546PubMed Schernthaner G, Haber P, Krummer R, Ludwing H (1977) Lung elasticity in juvenile onset diabetes mellitus. Am Rev Respir Dis 116:544–546PubMed
35.
Zurück zum Zitat Villa MP, Bernardi F, Salardi S et al. (1988) Valutazione della funzionalità respiratoria nel bambino e nell’adolescente con diabete mellito di tipo 1. Riv Ital Ped 14:17–21 Villa MP, Bernardi F, Salardi S et al. (1988) Valutazione della funzionalità respiratoria nel bambino e nell’adolescente con diabete mellito di tipo 1. Riv Ital Ped 14:17–21
36.
Zurück zum Zitat Villa MP, Cacciari E, Bernardi F, Cicognami A, Salazardi S, Zapulla F (1988) Bronchial reactivity in diabetic patients. Relationship to duration of diabetes and degree of glycemic control. Am J Dis Child 142:726–729PubMed Villa MP, Cacciari E, Bernardi F, Cicognami A, Salazardi S, Zapulla F (1988) Bronchial reactivity in diabetic patients. Relationship to duration of diabetes and degree of glycemic control. Am J Dis Child 142:726–729PubMed
Metadaten
Titel
Diffusing capacity for carbon monoxide in children with type 1 diabetes
verfasst von
M. P. Villa
M. Montesano
M. Barreto
J. Pagani
M. Stegagno
G. Multari
R. Ronchetti
Publikationsdatum
01.11.2004
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 11/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1548-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Frauen bekommen seltener eine intensive Statintherapie

30.04.2024 Statine Nachrichten

Frauen in den Niederlanden erhalten bei vergleichbarem kardiovaskulärem Risiko seltener eine intensive Statintherapie als Männer. Ihre LDL-Zielwerte erreichen sie aber fast ähnlich oft.

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.